Optimizing Treatment Pathways in CLL and MCL: Evaluating and Applying Recent Data on BTK Inhibitors

Do you struggle with how to optimally interpret chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL)? Hear from the experts.

Credit available for this activity expires: 3/29/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000542?ecd=bdc_podcast_libsyn_mscpedu